Champions Oncology (CSBR) Asset Utilization Ratio (2011 - 2026)
Champions Oncology (CSBR) posted quarterly Asset Utilization Ratio of 2.14 for Q2 2026, up 18.54% year-over-year from 1.81 in Q2 2025, and up 8.42% quarter-over-quarter from 1.98 in Q1 2026.
Champions Oncology (CSBR) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Champions Oncology's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 2.14 for Q2 2026.
- In Q2 2026, Asset Utilization Ratio rose 18.54% year-over-year to 2.14; the TTM figure through Apr 2026 stood at 2.14 (up 18.54% YoY), while the FY2026 annual figure was 2.0, up 2.85% from the prior year.
- Asset Utilization Ratio for Q2 2026 stood at 2.14, up from 1.98 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 2.14 in Q2 2026, with the low at 1.42 in Q2 2022.
- The 5-year median for Asset Utilization Ratio is 1.8 (2024), against an average of 1.77.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio advanced 24.34% in 2024, then slipped 10.59% in 2025.
- Champions Oncology's Asset Utilization Ratio stood at 1.53 in 2022, then climbed by 12.32% to 1.72 in 2023, then increased by 24.34% to 2.14 in 2024, then retreated by 9.87% to 1.92 in 2025, then rose by 11.38% to 2.14 in 2026.
- Business Quant data shows CSBR's Asset Utilization Ratio at 2.14 in Q2 2026, 1.98 in Q1 2026, and 1.92 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 2.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.14 |
| Jan 31, 2026 | 1.98 |
| Oct 31, 2025 | 1.92 |
| Jul 31, 2025 | 1.81 |
| Apr 30, 2025 | 1.81 |
| Jan 31, 2025 | 2.10 |
| Oct 31, 2024 | 2.14 |
| Jul 31, 2024 | 2.02 |
| Apr 30, 2024 | 1.90 |
| Jan 31, 2024 | 1.79 |
| Oct 31, 2023 | 1.72 |
| Jul 31, 2023 | 1.64 |
| Apr 30, 2023 | 1.53 |
| Jan 31, 2023 | 1.48 |
| Oct 31, 2022 | 1.53 |
| Jul 31, 2022 | 1.48 |
| Apr 30, 2022 | 1.42 |
| Jan 31, 2022 | 1.49 |
| Oct 31, 2021 | 1.55 |
| Jul 31, 2021 | 1.53 |